Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.66
Data as of Jul 31
 -0.40 / -4.42%
Today’s Change
5.84
Today|||52-Week Range
11.47
+14.85%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$364.1M

Company Description

Supernus Pharmaceuticals, Inc. develops and commercializes products for the treatment of central nervous system. It also develops multiple product candidates in psychiatry to address the large market opportunity in the treatment of attention deficit hyperactivity disorder, or ADHD, including ADHD patients with impulsive aggression. The company markets their products in the U.S. through their own focused sales force targeting specialty physicians and seek strategic collaborations with other pharmaceutical companies to license their products outside the U.S. Its neurology portfolio consists of Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (extended release topiramate). The company's psychiatry product candidates include SPN-810 (molindone hydrochloride), SPN-812 and SPN-809. Supernus Pharmaceuticals was founded by Jack A. Khattar on March 30, 2005 and is headquartered in Rockville, MD.

Contact Information

Supernus Pharmaceuticals, Inc.
1550 East Gude Drive
Rockville Maryland 20850
P:(301) 838-2500
Investor Relations:
(301) 838-2522

Employees

Shareholders

Individual stakeholders46.04%
Other institutional27.77%
Mutual fund holders21.80%

Top Executives

Jack A. KhattarPresident, CEO, Director & Secretary
Gregory S. PatrickCFO, Vice President & Head-Investor Relations
Padmanabh P. BhattChief Scientific Officer & Senior Vice President
Stefan K. F. SchwabeChief Medical Officer, EVP-Research & Development
Jones Woody BryanVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.